In last trading session, GlycoMimetics Inc (NASDAQ:GLYC) saw 6.15 million shares changing hands with its beta currently measuring 2.17. Company’s recent per share price level of $0.24 trading at -$0.07 or -24.20% at ring of the bell on the day assigns it a market valuation of $15.16M. That closing price of GLYC’s stock is at a discount of -1370.83% from its 52-week high price of $3.53 and is indicating a premium of 4.17% from its 52-week low price of $0.23. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.92 million shares which gives us an average trading volume of 4.50 million if we extend that period to 3-months.
For GlycoMimetics Inc (GLYC), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 0 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
GlycoMimetics Inc (NASDAQ:GLYC) trade information
Upright in the red during last session for losing -24.20%, in the last five days GLYC remained trading in the red while hitting it’s week-highest on Monday, 07/22/24 when the stock touched $0.24 price level, adding 27.27% to its value on the day. GlycoMimetics Inc’s shares saw a change of -90.03% in year-to-date performance and have moved -20.59% in past 5-day. GlycoMimetics Inc (NASDAQ:GLYC) showed a performance of -29.58% in past 30-days. Number of shares sold short was 2.85 million shares which calculate 0.3 days to cover the short interests.
GlycoMimetics Inc (GLYC) estimates and forecasts
Statistics highlight that GlycoMimetics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -92.34% of value to its shares in past 6 months, showing an annual growth rate of -6.90% while that of industry is 13.40. Apart from that, the company came lowering its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 13.11% during past 5 years.
GLYC Dividends
GlycoMimetics Inc is more likely to be releasing its next quarterly report in August and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
GlycoMimetics Inc (NASDAQ:GLYC)’s Major holders
Insiders are in possession of 3.58% of company’s total shares while institution are holding 51.63 percent of that, with stock having share float percentage of 53.55%. Investors also watch the number of corporate investors in a company very closely, which is 51.63% institutions for GlycoMimetics Inc that are currently holding shares of the company. BVF INC/IL is the top institutional holder at GLYC for having 9.54 million shares of worth $28.63 million. And as of 2024-03-31, it was holding 14.8217 of the company’s outstanding shares.
The second largest institutional holder is ARTAL GROUP S.A., which was holding about 8.59 million shares on 2024-03-31. The number of shares represents firm’s hold over 13.3383 of outstanding shares, having a total worth of $25.77 million.
